Literature DB >> 25696266

How to target uncertainty in Dutch invasive cardiovascular care.

G A J Jessurun, J O J Peels, F Zijlstra.   

Abstract

Current meetings of the Netherlands Society of Cardiology and the Working Group on Intervention Cardiology have shown that new strategic developments in the Dutch healthcare system have created much turbulence and uncertainty amongst members of the organisations. Both on-site and off-site new cardiac centres with and without surgical backup, respectively, are arising or being planned throughout the Netherlands. These strategic adaptations are related to service delivery failure, despite appropriate quality measures. To understand the reasoning behind this uncertainty and how to deal with it, we need to explore its origin and thinking. Its rationale is based on the assumption that each organisation relies on its ability to survive through innovation and transformation. Cardiologists and cardiac surgeons are key players in a large group of stakeholders participating in the chain of cardiovascular care. In addition, the Dutch healthcare system is deeply embedded in a historical sociopolitical environment. This may explain why ongoing uncertainty may beget more uncertainty. What are the consequences for the content of the route forward?

Entities:  

Keywords:  chaos; quality control; strategy; volume-outcome

Year:  2004        PMID: 25696266      PMCID: PMC2497156     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  16 in total

1.  The relation between volume and outcome in health care.

Authors:  K Sheikh
Journal:  N Engl J Med       Date:  1999-09-30       Impact factor: 91.245

2.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

3.  Relation of total annual coronary angioplasty volume of physicians and hospitals on outcomes of primary angioplasty for acute myocardial infarction (data from the 1995 Coronary Angioplasty Reporting System of the New York State Department of Health).

Authors:  Babak A Vakili; David L Brown
Journal:  Am J Cardiol       Date:  2003-03-15       Impact factor: 2.778

4.  Reflections on the Danish Revolution.

Authors:  Mark C Petrie; Felix Zijlstra
Journal:  Eur Heart J       Date:  2004-04       Impact factor: 29.983

5.  Health care system chaos should spur innovation: summary of a report of the Society of General Internal Medicine Task Force on the Domain of General Internal Medicine.

Authors:  Eric B Larson
Journal:  Ann Intern Med       Date:  2004-04-20       Impact factor: 25.391

6.  Volume-outcome relation for physicians and hospitals performing angioplasty for acute myocardial infarction in New York state.

Authors:  B A Vakili; R Kaplan; D L Brown
Journal:  Circulation       Date:  2001-10-30       Impact factor: 29.690

7.  Relation between operator and hospital volume and outcomes following percutaneous coronary interventions in the era of the coronary stent.

Authors:  P D McGrath; D E Wennberg; J D Dickens; A E Siewers; F L Lucas; D J Malenka; M A Kellett; T J Ryan
Journal:  JAMA       Date:  2000-12-27       Impact factor: 56.272

8.  Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy.

Authors:  D J Magid; B N Calonge; J S Rumsfeld; J G Canto; P D Frederick; N R Every; H V Barron
Journal:  JAMA       Date:  2000-12-27       Impact factor: 56.272

9.  The effect of organized systems of trauma care on motor vehicle crash mortality.

Authors:  A B Nathens; G J Jurkovich; P Cummings; F P Rivara; R V Maier
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

10.  Operator volume and outcome of patients undergoing coronary stent placement.

Authors:  A Kastrati; F J Neumann; A Schömig
Journal:  J Am Coll Cardiol       Date:  1998-10       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.